Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +27.07% | +26.06% | +42.31% | +22.90% | +25.48% |
| Weighted Average Shares Diluted Growth | +27.07% | +26.05% | +42.31% | +22.90% | +25.48% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | -100.00% | -100.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +3.80% | +14.97% | +87.48% | -26.32% | -8.22% |
| Book Value per Share Growth | +0.00% | +45.03% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +276.46% | -13.20% | +132.15% | -79.51% | -80.40% |
| R&D Expense Growth | +72.55% | +2.90% | -14.35% | -30.77% | -52.18% |
| SG&A Expenses Growth | -21.27% | +10.29% | +12.43% | -11.61% | +47.70% |